YARROW BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
YARROW BIOSCIENCE, INC. (YARW) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 220.64 thousand shares for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-06-03.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-06-03
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-09-30 was 0.00 shares.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-06-30 was 0.00 shares.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-03-31 was 6.77K shares.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 25.57K shares, a 519.63% increase from fiscal 2023.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 4.13K shares, a 84.27% decline from fiscal 2022.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 26.23K shares, a 93.98% decline from fiscal 2021.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 435.57K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 10 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | 220.64K shares S-4/A · filed 2026-06-03 | ||||
| 2024-12-31 | 25.57K shares 10-K · filed 2025-03-06 | ||||
| 2023-12-31 | 4.13K shares 10-K · filed 2024-03-01 | ||||
| 2022-12-31 | 26.23K shares 10-K · filed 2023-03-14 | ||||
| 2021-12-31 | 435.57K shares 10-K · filed 2022-03-17 | ||||
| 2020-12-31 | 259.26K shares 10-K · filed 2021-03-04 | ||||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2018-11-07 | 6.77K shares 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | 6.77K shares 10-Q · filed 2018-08-01 | |||
| 2018-03-31 | 6.77K shares 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |